Ikarian Capital, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Ikarian Capital, LLC

$573 Million
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $13 Million - $18.9 Million	-115,100 Reduced 99.14%	1,000 $158,000
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $6.23 Million - $9.41 Million	-66,500 Reduced 36.42%	116,100 $15 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $12.1 Million - $22.5 Million	180,477 Added 8501.04%	182,600 $17.6 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $2.05 Million - $2.47 Million	-19,977 Reduced 90.39%	2,123 $257,000
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $19.5 Million - $28.8 Million	-183,300 Reduced 89.24%	22,100 $2.53 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $24.1 Million - $32 Million	205,400 New	205,400 $28.3 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $1.12 Million - $1.76 Million	-14,800 Reduced 14.8%	85,200 $9.42 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $6.27 Million - $8.84 Million	100,000 New	100,000 $7.5 Million
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $25.2 Million - $36.1 Million	-399,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $2.91 Million - $3.75 Million	37,700 Added 10.42%	399,400 $36 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $20.6 Million - $28.8 Million	311,700 Added 623.4%	361,700 $33.4 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $3.47 Million - $4.34 Million	-50,000 Reduced 50.0%	50,000 $3.89 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $29 Million - $67.7 Million	-401,000 Reduced 80.04%	100,000 $7.45 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $50 Million - $71.2 Million	398,400 Added 388.3%	501,000 $85.4 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $12.7 Million - $17.2 Million	100,000 Added 3846.15%	102,600 $14.4 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $9.3 Million - $17.2 Million	-100,000 Reduced 97.47%	2,600 $417,000
Q4 2019 Jan 31, 2020	BUY	$76.53 - $135.58 $7.85 Million - $13.9 Million	102,600 New	102,600 $13.2 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.3 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.13 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$787 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$548 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$537 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Account